All News #Library
Biotech
Delta-Fly Updates On DFP-10917 & Venetoclax Combination Study
28 Feb 2025 //
BUSINESSWIRE
Delta-Fly Pharma Begins Promising AML Phase I/II Study
28 Oct 2024 //
BUSINESSWIRE
Delta-Fly Notice to Conduct the Ph I/II of DFP-10917 combined with Venetoclax
08 Apr 2024 //
BUSINESSWIRE
Delta-Fly: FDA submission of the protocol of the Phase I/II study of DFP-10917
11 Mar 2024 //
BUSINESSWIRE
Delta-Fly Pharma: Update on the R&D status of DFP-10917 and DFP-14927
05 Jan 2024 //
BUSINESSWIRE

Market Place
Sourcing Support